Heartburn Research Today is a free monthly online journal that collates and summarizes the latest research about Heartburn, including details on symptoms, causes, prevention, treatment, diet, reflux, drugs.

Volume 1 (2004), Issue 2 (November)

1. Relationship between symptom response and oesophageal acid exposure after medical and surgical treatment for gastro-oesophageal reflux disease.
   Br J Surg, 91(11): 1460-5. [Abstract] [Full-text]
2. A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn.
   Aliment Pharmacol Ther, 20(9): 975-82. [Abstract] [Full-text]
3. Review article: gastro-oesophageal reflux disease as a functional gastrointestinal disorder.
   Aliment Pharmacol Ther, 20: 50-5. [Abstract] [Full-text]
4. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
   Aliment Pharmacol Ther, 20(9): 969-74. [Abstract] [Full-text]
5. Review article: diagnosis and management of night-time reflux.
   Aliment Pharmacol Ther, 20: 57-72. [Abstract] [Full-text]
6. Review article: sleep and its relationship to gastro-oesophageal reflux.
   Aliment Pharmacol Ther, 20: 39-46. [Abstract] [Full-text]
7. Review article: impact of night-time reflux on lifestyle - unrecognized issues in reflux disease.
   Aliment Pharmacol Ther, 20: 3-13. [Abstract] [Full-text]
8. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux.
   Gut, 53(12): 1730-5. [Abstract] [Full-text]
9. Multicenter, prospective, double-blind, randomized trial of laparoscopic nissen vs anterior 90 degrees partial fundoplication.
   Arch Surg, 139(11): 1160-7. [Abstract] [Full-text]
10. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex.
    Scand J Gastroenterol, 39(11): 1040-5. [Abstract] [Full-text]
11. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States.
    Am J Gastroenterol, 99(11): 2210-6. [Abstract] [Full-text]
12. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
    Aliment Pharmacol Ther, 20(10): 1171-9. [Abstract] [Full-text]
13. Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
    Aliment Pharmacol Ther, 20(10): 1161-9. [Abstract] [Full-text]
14. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
    Aliment Pharmacol Ther, 20(10): 1105-14. [Abstract] [Full-text]

© 2004-2008 Heartburn Research Today. All Rights Reserved.